Citations

Showing 10 of 108083 citations.

Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection
Allegretti, Jessica R. , Khanna, Sahil , Feuerstadt, Paul

Mayo Clinic

American Journal of Gastroenterology | January 25, 2023 | Volume: 118 | Issue: 8 | Pages: 1303-1306

10.14309/ajg.0000000000002195 | PMID 36695753 Get It

Improvement in Blood Pressure Control in Safety Net Clinics Receiving 2 Versions of a Scalable Quality Improvement Intervention: BP MAP A Pragmatic Cluster Randomized Trial
Fontil, Valy , Modrow, Madelaine Faulkner , Cooper‐DeHoff, Rhonda M. , Wozniak, Gregory , Rakotz, Michael , Todd, Jonathan , Azar, Kristen , Murakami, Linda , Sanders, Margaret , Chamberlain, Alanna M. , O’Brien, Emily C. , Lee, April , Pletcher, Mark J. , O'Brien, Emily , Lee, April , Carton, Thomas , Pletcher, Mark J , Chamberlain, Alanna M , Azar, Kristen , Rakotz, Michael , Faulkner Modrow, Madelaine , Cooper‐DeHoff, Rhonda M. , Fontil, Valy , Carton, Thomas W.

Mayo Clinic

Journal of the American Heart Association | January 25, 2023 | Volume: 12 | Issue: 3 | Pages: No page available

10.1161/jaha.121.024975 | PMID 36695297 Get It

Background Uncontrolled blood pressure (BP) remains a leading cause of death in the United States. The American Medical Association developed a quality improvement program to improve BP control, but it is unclear how to efficiently implement this program at scale across multiple health systems. Methods and Results We conducted BP MAP (Blood Pressure Measure Accurately, Act Rapidly, and Partner With Patients), a comparative effectiveness trial with clinic‐level randomization to compare 2 scalable versions of the quality improvement program: Full Support (with support from quality improvement expert) and Self‐Guided (using only online materials). Outcomes were clinic‐level BP control (<140/90 mm Hg) and other BP‐related process metrics calculated using electronic health record data. Difference‐in‐differences were used to compare changes in outcomes from baseline to 6 months, between intervention arms, and to a nonrandomized Usual Care arm composed of 18 health systems. A total of 24 safety‐net clinics in 9 different health systems underwent randomization and then simultaneous implementation. BP control increased from 56.7% to 59.1% in the Full Support arm, and 62.0% to 63.1% in the Self‐Guided arm, whereas BP control dropped slightly from 61.3% to 60.9% in the Usual Care arm. The between‐group differences‐in‐differences were not statistically significant (Full Support versus Self‐Guided=+1.2% [95% CI, −3.2% to 5.6%], P =0.59; Full Support versus Usual Care=+3.2% [−0.5% to 6.9%], P =0.09; Self‐Guided versus Usual Care=+2.0% [−0.4% to 4.5%], P =0.10). Conclusions In this randomized trial, 2 methods of implementing a quality improvement intervention in 24 safety net clinics led to modest improvements in BP control that were not statistically significant. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03818659.
Aging affects the number and morphological heterogeneity of rat phrenic motor neurons and phrenic motor axons
Fogarty, Matthew J. , Sieck, Gary C. , Sieck, Gary , Fogarty, Matthew J

Mayo Clinic

Physiological Reports | January 25, 2023 | Volume: 11 | Issue: 2 | Pages: No page available

10.14814/phy2.15587 | PMID 36695744 Get It

Abstract Diaphragm muscle (DIAm) motor units comprise a phrenic motor neuron (PhMN), the phrenic nerve and the muscle fibers innervated, with the size of PhMNs and axons characteristic of motor unit type. Smaller PhMNs and their axons comprise slow (type S) and fatigue‐resistant (type FR) DIAm motor units, while larger PhMNs and their axons comprise more fatigable (type FF) motor units. With aging, we have shown a loss of larger PhMNs, consistent with selective atrophy of type IIx/IIb DIAm fibers and reduced maximum DIAm force. In the present study, we hypothesized that with aging there is a loss of larger myelinated phrenic α motor axons. Female and male young (6 months) and old (24 months) Fischer 344 rats were studied. PhMNs were retrogradely labeled by intrapleural injection of 488‐conjugated CTB. The phrenic nerves were excised ~1 cm from the DIAm insertion and mounted in resin, and phrenic α motor axons were delineated based on size (i.e., >4 μm diameters). In older rats, the number of larger PhMNs and larger phrenic α motor axons were reduced. There were no differences in non‐α axons. In addition, there was evidence of demyelination of larger phrenic α motor axons in older rats. Together, these findings are consistent with the selective age‐related vulnerability of larger PhMNs and denervation of type FF motor units, which may underlie DIAm sarcopenia.
Bidirectional needs assessment of otolaryngology–head and neck surgery short‐term surgical trips to Ethiopia and Kenya
Chweya, Cynthia M. , Ryder, C. Yoonhee , Fei‐Zhang, David J. , Green, Katerina J. , Zemene, Yilkal , Okerosi, Samuel , Wiedermann, Joshua P. , Green, Katerina , Fei-Zhang, David

Mayo Clinic

Laryngoscope Investigative Otolaryngology | January 25, 2023 | Volume: 8 | Issue: 1 | Pages: 303-312

10.1002/lio2.1014 | PMID 36846413 Get It

AbstractObjectivesTo create an otolaryngology‐specific needs assessment tool for short‐term global surgical trips and to describe our findings from its implementation.MethodsSurveys 1 and 2 were developed based on a literature review and disseminated to Low‐Middle Income (LMIC) hosting institutions in Kenya and Ethiopia and to High‐Income surgical trip participants (HIC), respectively. Respondents were otolaryngologists identified online, through professional organizations, and by word‐of‐mouth, who had participated in a surgical trip of <4 weeks.ResultsHIC and LMIC respondents shared similar goals of expanding host surgical skills through education and training while building sustainable partnerships. Discrepancies were identified between LMIC desired surgical skills and supply needs and HIC current practices. Microvascular reconstruction (17.6%), advanced otologic surgery (17.6%), and FESS (14.7%) were most desired skills and high‐demand equipment needs were FESS sets (89%), endoscopes (78%), and surgical drills (56%). Frequently taught techniques included advanced otologic surgery (36.6%), congenital anomaly surgery (14.6%), and FESS (14.6%) with the largest gap between LMIC‐need and HIC‐offerings being in microvascular reconstruction (17.6% vs. 0%). We also highlight the discrepancy in expectations of responsibility for trip logistics, research, and patient follow‐up.ConclusionWe created and implemented the first otolaryngology‐specific needs assessment tool in the literature. With its implementation in Ethiopia and Kenya, we were able to identify unmet needs as well as attitudes and perceptions of LMIC and HIC participants. This tool may be adapted and utilized to assess specific needs, resources, and goals of both host and visiting teams to facilitate successful global partnerships.Level of EvidenceLevel VI.
Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure
Challa, A B, Skidan, V I, Goda, A Y, Nkomo, V T, Miller, W L, Pislaru, S, Challa, Apurva, Goda, Ahmed Y., Nkomo, V T, Miller, Wayne L.

Mayo Clinic

European Heart Journal | January 25, 2023 | Volume: 44 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehac779.032 Get It

Abstract Funding Acknowledgements Type of funding sources: None. Background Right heart and renal dysfunction occurring due to volume fluid redistribution remain a front-line issue in the development of the syndrome of congestion in chronic heart failure (HF). Quantitative total blood volume (TBV) measurements and Speckle-tracking Echo (STE) provide complementary information on the myocardial function which allows for providing a more integrated assessment of clinical status and outcomes. Purpose We hypothesize adverse outcomes in patients with heart failure (HF) who have expansion of TBV, right ventricular (RV) and renal dysfunction. Methods This is a prospective study and a total of 66 participants NYHA class III&IV with chronic HF are enrolled from 2014-2022. TBV, right heart catheterization, TTE, TEE, and kidney function tests is performed. STE is calculated using TomTec software for all heart chambers. Patients is divided into 1-st group of the total participants, 2-nd group is patients adverse outcomes which are heart transplant (HT) or death, 3rd group is of alive patients. Simple, multivariable linear regression analyses is used to evaluate associations between TBV, cardiac and renal function. Statistical analyses is performed using JMP, BlueSky, and two-sided with P-values &lt;0.05 considered to be statistically. Results Of 66 patients, the 1-st group has 66 patients, the 2nd group has 44 patients out of which deceased are 32 patients (48.4%), HT has 12 patients (18.1%), and the 3rd group has 22 patients (33.3%). In the 2nd group, out of the 44 patients, 35 (79.5%) patients have HFrEF, and 9 (20.4%) patients presented HFpEF. In the 3rd group out of 22 patients, 15 (68.2%) have HFrEF, and 7 (31.8%) patients have HFpEF. RV dimensions are significantly related to TBV in all groups of participants (Table 1). In the total patients, TBV is directly correlated to a moderate degree with EDSRV (r = 0.51, P &lt; 0.001), ESSRV (r = 0.44, P &lt; 0.001) and FAC (r = 0.40, P &lt; 0.001). More significant moderate and strong relationships are observed in patients with adverse outcome between TVB and EDSRV (r = 0.54, P &lt; 0.001), ESSRV (r = 0.65, P &lt; 0.001) and FAC (r = 0.48, P &lt; 0.001). In group 1, weak and direct association of TBV and RV GLS, FW LS, FW LSR, and RA reservoir strain. In the 2nd group, TBV directly correlated to a moderate degree with FW LS (r = 0.41, P = 0.005) and FW LSR (r = 0.43, P = 0.002). Similar relationships in the 2nd group are observed between TBV and renal function parameters (TBV and eGFR (r = 0.53, P &lt; 0.001)). The direct and weak correlation obtained between TBV and BUN in both 1st and 2nd groups. In patients with adverse outcomes, TBV is directly proportional to LV Diastolic BP. Conclusion The association among intravascular volume and parameters of RV dilatation, myocardial and renal dysfunction in patients with chronic HF is associated with adverse outcomes. Understanding the impact of all these variables guide optimal and effective individualized HF management and therapy.
The relative risk of ischemic cerebrovascular accident in patients with Von Willebrand disease
Olagunju, Abdulbaril , Mihyawi, Nawfal, Fath, Ayman R. , Bhattarai, Bikash, Eldaly, Abdullah S. , Forst, Beani, Mantha, Yogamaya , Yeneneh, Beeletsega

Mayo Clinic

Journal of Investigative Medicine | January 25, 2023 | Volume: 71 | Issue: 4 | Pages: 394-399

10.1177/10815589221150642 | PMID 36695432 Get It

Cerebrovascular accident (CVA) is one of the leading causes of death in the United States. Von Willebrand factor plays an important role in platelet activation and adhesion. It remains unclear whether Von Willebrand disease (vWD) is associated with a decreased risk of developing CVA. The study aimed to compare the relative risk (RR) of CVA in patients with and without vWD. We queried the National Inpatient Sample from 2009 to 2014 for discharge data and records for vWD and CVA using International Classification of Diseases, Ninth-Revision codes. The unadjusted and adjusted RR of CVA in patients with and without vWD were estimated using log-binomial model. Descriptive measures including means, medians, standard deviations, and range were presented based on normality test of continuous data. The prevalence of CVA was lower in patients with vWD than in those without vWD (1.31% vs 2.04%), with a RR of 0.64 (95% confidence interval (CI): 0.60–0.68). After adjusting for common CVA risk factors, the RR remained lower in vWD patients: 0.81 (95% CI: 0.76–0.86). vWD is associated with a lower RR of developing CVA. This suggests that deficiency of Von Willebrand factor is potentially protective against the development of CVA. To the best of our knowledge, this is the first study in humans to compare the RR of CVA in patients with and without vWD. Future studies are needed to explore causal relationships and therapeutic benefits.
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee
Goldman, Jason D. , Pouch, Stephanie M. , Woolley, Ann E. , Booker, Sarah E. , Jett, Courtney , Fox, Cole, Berry, Gerald J. , Dunn, Kelly E., Kittleson, M. , Lee, Dong Heun , Levine, Deborah J. , Marboe, Charles C. , Taimur, Sarah , Te, Helen S. , Fisher, Cynthia E. , Sellers, Marty T. , Levi, Marilyn E. , Klassen, David K. , Danziger‐Isakov, Lara , Lee, Dong Heun , Marklin, Gary , Trindade, Anil J , Michaels, Marian G , La Hoz, Ricardo M , Danziger-Isakov, Lara , Pouch, Stephanie M , Berry, Gerald J , Ho, Chak‐Sum , Razonable, Raymund R. , Anesi, Judith A. , Wood, R. Patrick, Zaffiri, Lorenzo , Hoz, Ricardo M. La

Mayo Clinic

Transplant Infectious Disease | January 25, 2023 | Volume: 25 | Issue: 1 | Pages: No page available

10.1111/tid.14013 | PMID 36694448 Get It

AbstractBackgroundDecisions to transplant organs from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) nucleic acid test‐positive (NAT+) donors must balance risk of donor‐derived transmission events (DDTE) with the scarcity of available organs.MethodsOrgan Procurement and Transplantation Network (OPTN) data were used to compare organ utilization and recipient outcomes between SARS‐CoV‐2 NAT+ and NAT– donors. NAT+ was defined by either a positive upper or lower respiratory tract (LRT) sample within 21 days of procurement. Potential DDTE were adjudicated by OPTN Disease Transmission Advisory Committee.ResultsFrom May 27, 2021 (date of OTPN policy for required LRT testing of lung donors) to January 31, 2022, organs were recovered from 617 NAT+ donors from all OPTN regions and 53 of 57 (93%) organ procurement organizations. NAT+ donors were younger and had higher organ quality scores for kidney and liver. Organ utilization was lower for NAT+ donors compared to NAT– donors. A total of 1241 organs (776 kidneys, 316 livers, 106 hearts, 22 lungs, and 21 other) were transplanted from 514 NAT+ donors compared to 21 946 organs from 8853 NAT– donors. Medical urgency was lower for recipients of NAT+ liver and heart transplants. The median waitlist time was longer for liver recipients of NAT+ donors. The match run sequence number for final acceptor was higher for NAT+ donors for all organ types. Outcomes for hospital length of stay, 30‐day mortality, and 30‐day graft loss were similar for all organ types. No SARS‐CoV‐2 DDTE occurred in this interval.ConclusionsTransplantation of SARS‐CoV‐2 NAT+ donor organs appears safe for short‐term outcomes of death and graft loss and ameliorates the organ shortage. Further study is required to assure comparable longer term outcomes. image
Smartphones and Threshold-Based Monitoring Methods Effectively Detect Falls Remotely: A Systematic Review
Torres‐Guzman, Ricardo A. , Maita, Karla C. , Maniaci, Michael J. , Paulson, Margaret R. , Maita, Karla , Maniaci, Michael J , Torres, Ricardo A , Ávila, Francisco R. , Garcia, John P. , Forte, Antonio J.

Mayo Clinic

Sensors | January 25, 2023 | Volume: 23 | Issue: 3 | Pages: 1323

10.3390/s23031323 | PMID 36772364 Get It

In the US, at least one fall occurs in at least 28.7% of community-dwelling seniors 65 and older each year. Falls had medical costs of USD 51 billion in 2015 and are projected to reach USD 100 billion by 2030. This review aims to discuss the extent of smartphone (SP) usage in fall detection and prevention across a range of care settings. A computerized search was conducted on six electronic databases to investigate the use of remote sensing technology, wireless technology, and other related MeSH terms for detecting and preventing falls. After applying inclusion and exclusion criteria, 44 studies were included. Most of the studies targeted detecting falls, two focused on detecting and preventing falls, and one only looked at preventing falls. Accelerometers were employed in all the experiments for the detection and/or prevention of falls. The most frequent course of action following a fall event was an alarm to the guardian. Numerous studies investigated in this research used accelerometer data analysis, machine learning, and data from previous falls to devise a boundary and increase detection accuracy. SP was found to have potential as a fall detection system but is not widely implemented. Technology-based applications are being developed to protect at-risk individuals from falls, with the objective of providing more effective and efficient interventions than traditional means. Successful healthcare technology implementation requires cooperation between engineers, clinicians, and administrators.
Mechanism of Action and Structure–Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor
Dengler, Daniela G. , Harikumar, Kaleeckal G. , Yen, Alice, Sergienko, Eduard , Miller, Laurence J. , Miller, Laurence J , Harikumar, Kaleeckal G

Mayo Clinic

Membranes | January 25, 2023 | Volume: 13 | Issue: 2 | Pages: 150

10.3390/membranes13020150 | PMID 36837653 Get It

As part of an ongoing effort to develop a drug targeting the type 1 cholecystokinin receptor (CCK1R) to help prevent and/or treat obesity, we recently performed a high throughput screening effort of small molecules seeking candidates that enhanced the action of the natural agonist, CCK, thus acting as positive allosteric modulators without exhibiting intrinsic agonist action. Such probes would be expected to act in a temporally finite way to enhance CCK action to induce satiety during and after a meal and potentially even modulate activity at the CCK1R in a high cholesterol environment present in some obese patients. The current work focuses on the best scaffold, representing tetracyclic molecules identified through high throughput screening we previously reported. Extensive characterization of the two top “hits” from the previous effort demonstrated them to fulfill the desired pharmacologic profile. We undertook analog-by-catalog expansion of this scaffold using 65 commercially available analogs. In this effort, we were able to eliminate an off-target effect observed for this scaffold while retaining its activity as a positive allosteric modulator of CCK1R in both normal and high cholesterol membrane environments. These insights should be useful in the rational medicinal chemical enhancement of this scaffold and in the future development of candidates to advance to pre-clinical proof-of-concept and to clinical trials.